• Home
  • News
  • Analysis
  •  
    Regions
    • Australasia
    • Southeast Asia
    • Greater China
    • North Asia
    • South Asia
    • North America
    • Europe
    • Central Asia
    • MENA
  •  
    Funds
    • LPs
    • Buyout
    • Growth
    • Venture
    • Renminbi
    • Secondary
    • Credit/Special Situations
    • Infrastructure
    • Real Estate
  •  
    Investments
    • Buyout
    • Growth
    • Early stage
    • PIPE
    • Credit
  •  
    Exits
    • IPO
    • Open market
    • Trade sale
    • Buyback
  •  
    Sectors
    • Consumer
    • Financials
    • Healthcare
    • Industrials
    • Infrastructure
    • Media
    • Technology
    • Real Estate
  • Events
  • Chinese edition
  • Data & Research
  • Weekly Digest
  • Newsletters
  • Sign in
  • Events
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)870 240 8859

      Email: customerservices@incisivemedia.com

      • Sign in
     
      • Saved articles
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • RSS
    • Twitter
    • LinkedIn
    • Newsletters
  • Free Trial
  • Subscribe
  • Weekly Digest
  • Chinese edition
  • Data & Research
    • Latest Data & Research
      2023-china-216x305
      Regional Reports

      The reports review the year's local private equity and venture capital activity and are filled with up-to-date data and intelligence on fundraising, investments, exits and M&A. The regional reports also feature information on key companies.

      Read more
      2016-pevc-cover
      Industry Review

      Asian Private Equity and Venture Capital Review provides an independent overview of the private equity, venture capital and M&A activities in the Asia region. It delivers insights on investments made, capital raised, sector specific figures and more.

      Read more
      AVCJ Database

      AVCJ Database is the ultimate link between Asian dealmakers and those who provide advisory, financial, legal and technological services to the private equity, venture capital and M&A industries. It is packed with facts and figures on more than 153,000 companies and almost 117,000 transactions.

      Read more
AVCJ
AVCJ
  • Home
  • News
  • Analysis
  • Regions
  • Funds
  • Investments
  • Exits
  • Sectors
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)870 240 8859

    Email: customerservices@incisivemedia.com

    • Sign in
 
    • Saved articles
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

China

avcj-hong-kong-2021-ipo
China biotech IPOs in Hong Kong to stay strong - AVCJ Forum

The frenzy for Chinese biotech developers listing in Hong Kong is expected to continue well into 2022, industry participants told the AVCJ Private Equity & Venture Forum.

  • Greater China
  • 26 November 2021
pills-drugs-pharma
China ocular drugs developer raises $63m

China’s Neurophth Biotechnology, a gene therapy developer for ocular diseases, has raised a RMB400 million ($63 million) Series C round led by SDIC China Merchants Investment and Sequoia Capital China.

  • Greater China
  • 24 November 2021
NetEase music spinout completes $449m Hong Kong IPO

Cloud Village, a music streaming business controlled by Chinese internet giant NetEase and backed by several private equity investors, has raised HK$3.5 billion ($449 million) through a Hong Kong IPO.

  • Greater China
  • 24 November 2021
ipo-plane-hand
China IPOs: The star still wanes

Proceeds from private equity-backed offerings on China’s Star Market are down 75% from their peak one year ago, reflecting ongoing regulatory interference and diminished investor confidence

  • Greater China
  • 24 November 2021
avcj-hong-kong-2021-china
Investors see China regulatory turbulence as short-term - AVCJ Forum

Regulatory uncertainty overshadowing China's technology sector is a temporary phenomenon, investors told the AVCJ Private Equity & Venture Forum, while noting that targeting areas favored by the government remains a safe play.

  • Greater China
  • 23 November 2021
business-handshake-agreement
Vision Fund adds managing partners in India, China

SoftBank Vision Fund has promoted Sumer Juneja, who heads up its India investments, and Dennis Chang, a China-focused partner, to managing partner level.

  • South Asia
  • 23 November 2021
Warburg Pincus backs China new materials business

Ambilight, a China-based new materials company focused on electrochromic (EC) components, has raised several hundred million dollars in Series C funding led by Warburg Pincus.

  • Greater China
  • 22 November 2021
solar-panels-2
Local turbulence drives China tech players abroad - AVCJ Forum

Regulatory uncertainty in China has encouraged local technology companies to go global rather than rely on a single market, the AVCJ Private Equity & Venture Forum heard.

  • Greater China
  • 18 November 2021
smart-car-autonomous-driving-sensor-01
Xiaomi invests $70m in China LiDAR specialist Hesai

Xiaomi Industrial Investment Fund, a vehicle controlled by smart devices brand Xiaomi, has invested $70 million in Hesai Technology, a China-based developer of sensors used in autonomous driving.

  • Greater China
  • 18 November 2021
avcj-summit-21
COVID-19 validates sector lens strategies – AVCJ Forum

COVID-19 has reinforced the argument for developing sectoral expertise that spans geographies, industry leaders told the AVCJ Private Equity & Venture Forum.

  • Greater China
  • 17 November 2021
education-money-endowment-mortar
Ascendent abandons China education take-private

A consortium led by Ascendent Capital Partners has abandoned its planned $230.6 million take-private of Tarena International, a China-based provider of adult professional and K-12 education services.

  • Greater China
  • 17 November 2021
China's Bits x Bites closes second food tech fund at $100m

Bits x Bites, a Chinese VC firm focused on agriculture and food technology such as alternative protein, has closed its second fund at $100 million, beating a target of $70 million.

  • Greater China
  • 17 November 2021
healthcare-pharma-lab-drug-biotech-01
CBC, APG launch China healthcare infra fund

Specialist healthcare investor CBC Group has teamed up with APG Asset Management to launch a $1.5 billion fund dedicated to the development of healthcare infrastructure in China.

  • Greater China
  • 16 November 2021
rpa-robot-enterprise-2
CMC, Goldman lead $150m round for China's Cyclone Robotics

Cyclone Robotics, a Shanghai-based robotic process automation (RPA) start-up, has raised $150 million in a Series C round led by CMC Capital Group and Goldman Sachs Asset Management.

  • Greater China
  • 16 November 2021
gaussian
Vision Fund backs China cleaning robot maker

SoftBank Vision Fund 2 and Capital Today have led a RMB1.2 billion ($188 million) Series C round for Chinese cleaning robot maker Gaussian Robotics.

  • Greater China
  • 15 November 2021
food
Centurium invests $100m in China caterer Meican

Centurium Capital has provided a $100 million Series E round for Meican, a Chinese corporate food services company.

  • Greater China
  • 12 November 2021
2021-11-11-20h20-01cover
AVCJ Hong Kong conference issue 2021

  • Greater China
  • 12 November 2021
avcj-20211109cvr-72
Weekly digest - November 11 2021

  • Region
  • 11 November 2021
China’s Red raises $500m at $20b valuation

Chinese social e-commerce app Xiaohongshu, also known as Red, has raised a $500 million round led by Temasek Holdings and Tencent Holdings at a valuation of $20 billion, up from $3 billion in 2018.

  • Greater China
  • 11 November 2021
china-risk-regulation-tightrope
China regulation: Shock and awe

A raft of rules, largely targeting the technology sector, has challenged business cases and thwarted exits in China. It is also contributing to tweaks in investment strategy

  • Greater China
  • 11 November 2021
imab-biotech-drug-healthcare
GL Capital leads $125m round for Hzymes Biotechnology

Wuhan-based Hzymes Biotechnology, a specialized enzymes developer, has raised RMB800 million ($125 million) in Series C funding led by healthcare specialist GL Capital

  • Greater China
  • 10 November 2021
Hong Kong IPOs: Winner by default

New York’s loss is expected to be Hong Kong’s gain as regulatory and political turbulence drives Chinese start-ups to look for alternative listing destinations – unless valuations become a sticking point

  • Greater China
  • 10 November 2021
China CRO Tripod raises $156m

Tripod Preclinical Research Laboratories, a China-based contract research organization (CRO) based in Nanjing, has raised RMB1 billion ($156 million) led by Ruihua Capital, Lilly Asia Ventures (LAV) and GL Ventures.

  • Greater China
  • 09 November 2021
saas-software-enterprise
Tiger Global leads $100m round for China HR SaaS player

Moka, a Chinese software-as-a-service (SaaS) provider specializing in human resources services, has raised a $100 million Series C led by Tiger Global Management.

  • Greater China
  • 05 November 2021
33 34 35
  • About AVCJ
  • Advertise
  • Contacts
  • About ION Analytics
  • Terms of use
  • Privacy policy
  • Group disclaimer
  • RSS
  • Twitter
  • LinkedIn
  • Newsletters

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013